A prominent biochemist and his co-author are pulling one of their papers in the Journal of Biological Chemistry because…well, we’re not sure.
That’s because the retraction note is – as we’ve come to expect from JBC – not very informative.
Here’s the only explanation for the retraction of “The Down Syndrome Cell Adhesion Molecule (DSCAM) Interacts with and Activates Pak”:
Continue reading MacArthur awardee retracts signaling biology paper
A group of authors have withdrawn a 2011 Journal of Biological Chemistry paper, but then appear to have re-published almost the same paper a month later, only this time with just five of the original nine authors.
The paper, “HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity,” concerns a type of protein regulation important to cardiac stress. Written by researchers at the University of Chicago and the University of Pittsburgh, it has been cited 16 times, according to Thomson Scientific’s Web of Knowledge. It was rated “Exceptional” by a reviewer on the Faculty of 1000 website.
As we’ve come to expect from the JBC, here’s the full retraction notice, in all its inexplicit glory: Continue reading Déjà vu: JBC epigenetics paper is retracted, then largely re-published with fewer authors
A group of researchers at two universities in South Korea have retracted two cell biology papers featuring retinoic acid.
The most recent retraction appears in the Journal of Biological Chemistry. Although, in typical JBC fashion, the reason for it is anyone’s guess.
Here’s the unhelpful notice for “ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1:” Continue reading Cell biologists in South Korea retract two papers
A team led by David Latchman, a geneticist and administrator at University College London, has notched a mysterious retraction in the Journal of Biological Chemistry, and has had 25 more papers questioned on PubPeer.
The JBC notice for “Antiapoptotic activity of the free caspase recruitment domain of procaspase-9: A novel endogenous rescue pathway in cell death” is as useless as they come, a regular occurrence for the journal: Continue reading Prominent geneticist nets retraction, two corrections, and a lot of questions
The stories behind several recent inscrutable retraction notices became a bit more clear today when the Office of Research Integrity (ORI) issued findings in cases involving former researchers at the University of Chicago and the University of California, San Francisco.
The ORI found that H. Rosie Xing, a former assistant professor at the University of Chicago, Continue reading ORI sanctions former University of Chicago and UCSF scientists for faking findings
The former director of the X-ray crystallography lab at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, faked findings in three papers, according to the Office of Research Integrity.
Two of the three papers by Bijan Ahvazi were published in 2004, and later retracted in 2007, while the other was rejected: Continue reading Former NIH lab director faked findings in three papers: ORI
Sinead Miggin, a biologist at the National University of Ireland Maynooth, has withdrawn two papers from the Journal of Biological Chemistry (JBC) and has corrected another paper, in the Proceedings of the National Academy of Sciences (PNAS).
Here’s the opaque JBC notice for “14-3-3ϵ and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction,” a paper first published in November 2012: Continue reading Scientist in Ireland notches two mysterious retractions and a correction
A pair of researchers at the University of Maryland have retracted a third paper.
Here’s the unhelpful Journal of Biological Chemistry notice for “Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis,” by Suryakant Niture and Anil Jaiswal: Continue reading University of Maryland duo notches third retraction
Benjamin Barré, a genetics researcher who recently set up his own group at the University of Angers, is retracting four papers he worked on as a graduate student and postdoc.
Neil Perkins, in whose lab Barré was a postdoc, and Olivier Coqueret, in whose lab he did his PhD, tell Retraction Watch: Continue reading Geneticist retracting four papers for “significant problems”
Alfredo Fusco, who is under criminal investigation in Italy for scientific fraud, has had two more papers retracted.
Both are in the Journal of Biological Chemistry (JBC). Here are the two studies: Continue reading Cancer researcher facing criminal inquiry up to six retractions